One of the innovative treatments we offer is Tirzepatidea medication approved for adults with type 2 diabetes who have not achieved their blood sugar goals through lifestyle changes and other medications
Adults taking Eli Lilly's Zepbound lost 47% more weight on average than those on Novo Nordisk's Wegovy, Lilly reported from the first head-to-head trial comparing the two blockbuster GLP-1 obesity drugs
In the real world, people might see slightly less weight loss on average
Using a specialized formula, it works by breaking down fat cells through a process called lipolysis
Jacob Cohen, CEO and Founder of MangoRx, stated, We are excited to bring TRIM to market, offering consumers a cutting-edge, oral alternative to conventional weight loss injections
Does the B12 make the tirzepatide work better